Fig. 5.
Dose response anti-inflammatory effects of GLP1-SSM in comparison to methylprednisolone. a–c BALF neutrophil cell count a lung tissue MPO (mOD/min/g of tissue) assay activity b and BALF IL-6 concentration c in ALI mice at increasing peptide dose of s.c. GLP1-SSM (5–30 nmol/mouse) or methylprednisolone (3 mg/kg). * indicates p<0.05 compared to saline, SSM and GLP-1 treatment groups. #, + indicate p< 0.05 compared to GLP1-SSM 5 nmol and GLP1-SSM 15 nmol respectively (n=6/group).